Madam Speaker, I come to the floor tonight to talk about health care on this, the 6-month anniversary of the signing of the Patient Protection and Affordable Care Act in the East Wing of the White House, March 23 of this year. It's interesting because since the passage and signing of that bill into law, support has actually decreased rather than increased. This bill came to the House in the most unusual fashion. And in fact, our Speaker, Speaker Pelosi, was quoted as saying, ``We have to pass this bill so that you can find out what's in it.'' Well, that sounds pretty odd, doesn't it? It turns out the last 6 months have been just that, pretty odd. On August 31 of this year, Secretary Sebelius, Secretary of Health and Human Services, said, quoting, ``Unfortunately, there is still a great deal of confusion about what the reform law is and what it isn't. We have a lot of reeducation to do.'' I don't know if that means they will be setting up reeducation camps for some of us, but nevertheless you have to wonder about the implications of that statement. Now, it's interesting, I sit on a small little subcommittee on the Committee on Energy and Commerce. The committee is called Oversight and Investigations. Part of our jurisdiction is the Department of Health and Human Services, the Center for Medicare and Medicaid Services.…
Share & report
More from Michael Burgess
Madam Speaker, I yield myself 1 minute to point out, and to bring us back to the discussion at hand, that we are talking about only having American citizens voting in American elections. We are talking about checking a Department of Energy…
Mr. Speaker, I yield 2 minutes to the gentleman from Texas (Mr. Roy), another valuable member of the Rules Committee.
Madam Speaker, I thank my friend from New York for yielding, and I thank him for leading this discussion on behalf of the Rules Committee today. I wanted to come down and speak in support of the rule, and I want to speak in support of the…
Mr. Speaker, I thank Dr. Bucshon from Indiana for yielding me the time on such an important reauthorization that we are undertaking today. Mr. Speaker, 2018 was the last authorization for sickle cell research. Prior to that, it had been…





